Eledon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	47	44	31	63	22	8	15	29	22	197	330
Market Cap Growth	-	38.87%	-50.29%	186.24%	193.07%	-50.11%	-47.59%	29.92%	-88.76%	-40.30%	-
Enterprise Value	-3	-7	-24	-21	-92	-1	2	11	24	133	224
PE Ratio	-1.08	-1.08	-0.36	-1.83	-0.97	-0.47	-1.07	-2.19	-3.91	-4.37	-14.16
PB Ratio	0.57	0.52	0.37	0.39	0.12	0.80	1.04	1.48	-8.19	3.19	3.19
P/FCF Ratio	-1.10	-1.10	-1.10	-2.18	-1.45	-0.54	-1.27	-1.93	-4.50	-4.71	-15.60
P/OCF Ratio	-1.10	-1.10	-1.10	-2.18	-1.45	-0.54	-1.27	-1.93	-4.50	-4.78	-15.62
EV/EBITDA Ratio	0.18	0.18	0.28	0.57	3.99	0.06	-0.15	-0.88	-4.35	-2.95	-9.64
EV/EBIT Ratio	0.18	0.18	0.28	0.57	3.96	0.06	-0.15	-0.87	-4.33	-2.94	-9.63
EV/FCF Ratio	0.18	0.18	0.85	0.73	6.05	0.07	-0.18	-0.77	-4.97	-3.17	-10.61
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.03	-	-	-1.28	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.02	-0.01	-0.02	-	-	-0.61	-	-
Debt / FCF Ratio	-0.01	-0.01	-0.03	-0.03	-0.01	-0.02	-	-	-0.70	-	-
Quick Ratio	13.12	13.12	8.71	19.28	45.99	6.65	5.12	12.02	0.29	10.42	24.85
Current Ratio	14.41	14.41	9.19	20.07	46.57	7.54	5.63	13.19	0.30	10.90	25.34
Return on Equity (ROE)	-46.20%	-46.20%	-66.30%	-19.80%	-39.10%	-131.30%	-71.60%	-60.40%	-19.20%	-58.70%	-96.60%
Return on Assets (ROA)	-43.10%	-43.10%	-63.00%	-19.10%	-22.00%	-110.80%	-65.50%	-54.30%	-15.90%	-54.70%	-33.30%
Return on Capital (ROIC)	-51.31%	-51.31%	-104.12%	-22.38%	-9.68%	-163.97%	-97.02%	-67.45%	-688.32%	-73.33%	-22.67%
Earnings Yield	-85.03%	-92.58%	-280.45%	-54.69%	-103.49%	-212.88%	-93.30%	-45.59%	-25.54%	-22.89%	-7.06%
FCF Yield	-83.34%	-90.75%	-90.62%	-45.83%	-69.01%	-184.24%	-78.89%	-51.91%	-22.23%	-21.23%	-6.41%
Buyback Yield / Dilution	-72.34%	-72.34%	3.61%	-921.03%	-121.41%	-31.03%	-92.52%	-1122.10%	84.68%	-247.55%	-1455.06%
Total Shareholder Return	-72.34%	-72.34%	3.61%	-921.03%	-121.41%	-31.03%	-92.52%	-1122.10%	84.68%	-247.55%	-1455.06%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).